167 related articles for article (PubMed ID: 23469860)
1. P2X7 receptor activation contributes to an initial upstream mechanism of lipopolysaccharide-induced vascular dysfunction.
Chiao CW; da Silva-Santos JE; Giachini FR; Tostes RC; Su MJ; Webb RC
Clin Sci (Lond); 2013 Aug; 125(3):131-41. PubMed ID: 23469860
[TBL] [Abstract][Full Text] [Related]
2. P2X7 receptor activation amplifies lipopolysaccharide-induced vascular hyporeactivity via interleukin-1 beta release.
Chiao CW; Tostes RC; Webb RC
J Pharmacol Exp Ther; 2008 Sep; 326(3):864-70. PubMed ID: 18559654
[TBL] [Abstract][Full Text] [Related]
3. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats.
Gray GA; Schott C; Julou-Schaeffer G; Fleming I; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1218-24. PubMed ID: 1908734
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.
Szabó C; Mitchell JA; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Mar; 108(3):786-92. PubMed ID: 7682137
[TBL] [Abstract][Full Text] [Related]
5. Disruption of COX-2 and eNOS does not confer protection from cardiovascular failure in lipopolysaccharide-treated conscious mice and isolated vascular rings.
Stæhr M; Madsen K; Vanhoutte PM; Hansen PB; Jensen BL
Am J Physiol Regul Integr Comp Physiol; 2011 Aug; 301(2):R412-20. PubMed ID: 21543636
[TBL] [Abstract][Full Text] [Related]
6. An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide.
Scotland RS; Chauhan S; Vallance PJ; Ahluwalia A
Hypertension; 2001 Oct; 38(4):833-9. PubMed ID: 11641295
[TBL] [Abstract][Full Text] [Related]
7. Combined lack of estrogen receptors alpha and beta affects vascular iNOS protein expression.
Liang M; Ekblad E; Lydrup ML; Nilsson BO
Cell Tissue Res; 2003 Jul; 313(1):63-70. PubMed ID: 12827494
[TBL] [Abstract][Full Text] [Related]
8. P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide.
Clark AK; Staniland AA; Marchand F; Kaan TK; McMahon SB; Malcangio M
J Neurosci; 2010 Jan; 30(2):573-82. PubMed ID: 20071520
[TBL] [Abstract][Full Text] [Related]
9. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.
Wu CC; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Mar; 114(6):1273-81. PubMed ID: 7542532
[TBL] [Abstract][Full Text] [Related]
10. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats.
Wu CC; Chen SJ; Yen MH
Am J Physiol; 1998 Oct; 275(4):H1148-57. PubMed ID: 9746461
[TBL] [Abstract][Full Text] [Related]
12. Hemorrhagic shock-induced vascular hyporeactivity in the rat: relationship to gene expression of nitric oxide synthase, endothelin-1, and select cytokines in corresponding organs.
Liu LM; Dubick MA
J Surg Res; 2005 May; 125(2):128-36. PubMed ID: 15854664
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous venous dysfunction studied in vivo in the LPS-treated rabbit: implication of NO in saphenous vein hyporeactivity.
Vayssettes-Courchay C; Chataigneau M; Protin C; Ragonnet C; Verbeuren TJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):516-23. PubMed ID: 12677358
[TBL] [Abstract][Full Text] [Related]
14. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.
Thiemermann C; Szabó C; Mitchell JA; Vane JR
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):267-71. PubMed ID: 7678341
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice.
Chen Y; Boettger MK; Reif A; Schmitt A; Uçeyler N; Sommer C
Mol Pain; 2010 Mar; 6():13. PubMed ID: 20193086
[TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release.
Stegbauer J; Kuczka Y; Vonend O; Quack I; Sellin L; Patzak A; Steege A; Langnaese K; Rump LC
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R421-8. PubMed ID: 18046021
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dependence of matrix metalloproteinase-mediated vascular hyporeactivity caused by lipopolysaccharide.
Cena J; Lalu MM; Rosenfelt C; Schulz R
Eur J Pharmacol; 2008 Mar; 582(1-3):116-22. PubMed ID: 18242597
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase.
Li N; Klaassen CD
Toxicol Sci; 2005 Jan; 83(1):197-203. PubMed ID: 15483191
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
